374557-68-3

Upstream product

• 261959-40-4 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difuorophenyl)-3-(N-methylamino)-2-propanol 
• 100-11-8 1-bromomethyl-4-nitro-benzene 

Downstream Products

• 859231-15-5 2-(2,4-difluorophenyl)-1-[methyl(4-aminobenzyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ol 
• 1308719-22-3 N-[4-({[2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]methylamino}methyl)phenyl]propane-2-sulfonamide 
• 1308719-24-5 N-[4-({[2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]methylamino}methyl)phenyl]benzenesulfonamide 
• 1308719-25-6 N-[4-({[2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]methylamino}methyl)phenyl]-4-isopropylbenzenesulfonamide 
• 1308719-26-7 N-[4-({[2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]methylamino}methyl)phenyl]-4-nitrobenzenesulfonamide 

Relevant academic research and scientific papers

Design, synthesis, and invitro antifungal activity of 1-[(4-substituted-benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols

As part of our studies focused on the design of 1-[((hetero)aryl- and piperidinylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents, we report the development of new extended benzylamine derivatives substituted at the para p